M
COMPANY PROFILE
MedEye
A solution for medication and patient safety in health institutions
Valuation
$10–25M
Last recorded · 2016
Revenue
$1–10M
Latest reported FY
Headcount
<100
Current team size
Total funding
$10–50M
Disclosed equity funding
At a glance
- Founded
- 2010
- Headquarters
- 's-Hertogenbosch, Netherlands
- Sector
- Biotech & Life Sciences
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed4 investors entered at this stage
NSA Ventures
Icelandic Centre for Research
Startupbootcamp- HIHorizon 2020 FTI (Fast Track to Innovation)
Series A3 investors entered at this stage
EQT Life Sciences
Seventure Partners
BOM - Brabant Regional Development Agency
Series B and later1 investor entered at this stage
ECFG Venture Capital
Team profiled
12
named & role-tagged
Founders
Hidden — book a demo/100
quality score
Key operators
3
quality Hidden — book a demo/100
Potential founders
Hidden — book a demo
likely future founders
Startup mafia
Hidden — book a demo
alumni-founded startups
Talent movements
Hidden — book a demo in · Hidden — book a demo out
past 12 months
Source: Dealroom Talent Intelligence.
Global footprint
Workforce by country
3
countries with
team presence
team presence
🇮🇸 Iceland40%
🇳🇱 Netherlands40%
🇺🇸 United States20%
Market sentiment
An AI-synthesised read of the highest-engagement posts about MedEye on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See MedEye on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.